NATR
NATURES SUNSHINE PRODUCTS INC
+0.03 (+0.23%)13.12USD49.2K成交股數231M市值13.0本益比(近四季)0.5股價營收比+1.9%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 117M+3% | 123M+4% | 128M+12% | 115M+4% | 113M+2% | 118M+6% | 115M-2% | 111M+2% | 111M | 111M | 117M | 109M |
| 營業成本 | 30.8M | 32.9M | 34.3M | 32.5M | 31.7M | 33.1M | 32.9M | 31.7M | 32.0M | 30.0M | 31.9M | 31.7M |
| 毛利 | 86.2M+6% | 90.0M+6% | 94.0M+15% | 82.3M+4% | 81.6M+3% | 85.1M+5% | 81.8M-3% | 78.9M+3% | 79.0M | 81.2M | 84.6M | 76.9M |
| 毛利率 | 73.7% | 73.2% | 73.3% | 71.7% | 72.1% | 72.0% | 71.3% | 71.4% | 71.2% | 73.1% | 72.6% | 70.8% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 44.9M | 43.5M | 45.7M | 43.7M | 40.6M | 43.7M | 41.0M | 38.6M | 40.8M | 41.3M | 42.3M | 43.6M |
| 營業利益 | 5.5M-11% | 9.5M+110% | 9.0M+70% | 4.3M-24% | 6.2M+33% | 4.6M-22% | 5.3M-25% | 5.6M+3177% | 4.6M | 5.8M | 7.0M | 172K |
| 營業利益率 | 4.7% | 7.8% | 7.0% | 3.7% | 5.4% | 3.8% | 4.6% | 5.1% | 4.2% | 5.2% | 6.0% | 0.2% |
| 稅後淨利 | 3.5M-25% | 5.1M-1694% | 5.3M+23% | 5.3M+295% | 4.7M+105% | −321K-111% | 4.3M+79% | 1.3M+57% | 2.3M | 2.8M | 2.4M | 860K |
| 淨利率 | 3.0% | 4.2% | 4.2% | 4.6% | 4.2% | -0.3% | 3.8% | 1.2% | 2.1% | 2.5% | 2.1% | 0.8% |
| 稀釋 EPS | 0.19-24% | 0.29-1550% | 0.30+30% | 0.28+300% | 0.25+108% | -0.02-113% | 0.23+92% | 0.07+75% | 0.12 | 0.15 | 0.12 | 0.04 |
| 稀釋股數 | 18.3M | 17.9M | 18.0M | 19.0M | 18.8M | 19.1M | 18.9M | 19.1M | 19.2M | 19.5M | 19.7M | 19.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 82.5M | 87.6M | 95.6M | 81.3M | 86.5M | 84.7M | 78.7M | 68.7M | 77.8M | 76.0M | 69.0M | 65.7M |
| 應收帳款 | 13.9M | 12.5M | 15.1M | 13.0M | 11.4M | 9.5M | 11.4M | 11.3M | 9.7M | 9.5M | 12.5M | 10.5M |
| 存貨 | 71.7M | 67.1M | 67.3M | 69.3M | 64.9M | 59.4M | 62.3M | 62.3M | 62.7M | 66.3M | 65.9M | 67.5M |
| 總資產 | 260M | 261M | 265M | 255M | 253M | 241M | 245M | 236M | 247M | 240M | 236M | 235M |
| 有息負債 | – | – | – | – | – | – | – | – | 2.1M | – | – | – |
| 總負債 | 90.5M | 94.5M | 98.1M | 91.2M | 85.6M | 79.9M | 82.7M | 79.4M | 87.6M | 87.9M | 86.8M | 87.9M |
| 股東權益 | 169M | 167M | 167M | 164M | 167M | 161M | 163M | 156M | 160M | 152M | 149M | 147M |
| 負債比 | 34.8% | 36.2% | 37.0% | 35.8% | 33.9% | 33.2% | 33.7% | 33.7% | 35.4% | 36.6% | 36.7% | 37.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | 75.7M | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.8M | – | – | 2.6M+19% | – | – | – | 2.2M | – | – | 9.3M |
| 資本支出 | – | 2.5M | – | – | 1.1M | – | – | – | 3.7M | – | – | 2.3M |
| 自由現金流 | – | −4.3M | – | – | 1.5M-200% | – | – | – | −1.5M | – | – | 7.0M |
| 折舊攤銷 | – | 3.2M | – | – | 3.5M | – | – | – | 3.2M | – | – | 2.8M |
| 買回庫藏股 | – | 500K | – | – | 476K | – | – | – | 1.8M | – | – | 823K |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -3.5% | – | – | 1.3% | – | – | – | -1.4% | – | – | 6.4% |
營收拆解 2024 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2024 年度 · 454M
| 亞洲 | 208M | 45.7% | +3.3% |
|---|---|---|---|
| North America | 139M | 30.6% | -0.7% |
| 歐洲 | 84.8M | 18.7% | +4.6% |
| Latin America And Other | 22.9M | 5.0% | -1.2% |
地區2024 年度 · 454M
| 其他國家 | 204M | 45.0% | 0.0% |
|---|---|---|---|
| 美國 | 128M | 28.2% | -1.1% |
| 台灣 | 70.6M | 15.5% | +14.4% |
| 韓國 | 51.4M | 11.3% | +3.0% |
產品／服務2024 年度 · 418M
| General Health Products | 184M | 44.0% | +5.8% |
|---|---|---|---|
| Digestive Products | 112M | 26.7% | +7.6% |
| Cardiovascular Products | 81.7M | 19.6% | -2.3% |
| Weight Management Products | 20.5M | 4.9% | -38.4% |
| Personal Care Products | 17.8M | 4.3% | -2.7% |
| Shipping And Handling | 2.1M | 0.5% | +50.0% |
| Immunity Products 小計 | 38.7M | 9.3% | +19.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 480M | +5.7% | 19.5M | 4.1% | 1.06 | 28.8M |
| FY2024 | 454M | +2.0% | 7.7M | 1.7% | 0.40 | 14.3M |
| FY2023 | 445M | +5.5% | 15.1M | 3.4% | 0.77 | 30.7M |
| FY2022 | 422M | -5.0% | −390K | -0.1% | -0.02 | −6.9M |
| FY2021 | 444M | +15.3% | 30.2M | 6.8% | 1.42 | 27.9M |
| FY2020 | 385M | +6.3% | 23.0M | 6.0% | 1.07 | 32.8M |
| FY2019 | 362M | -0.7% | 6.9M | 1.9% | 0.34 | 3.4M |
| FY2018 | 365M | – | −1.2M | -0.3% | -0.04 | 17.0M |